Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001215422 | SCV001387167 | pathogenic | Charcot-Marie-Tooth disease, type 2 | 2019-10-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr679*) in the MFN2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in the heterozygous state in an individual who was referred for genetic testing for Charcot-Marie-Tooth disease (PMID: 25614874). Loss-of-function variants in MFN2 are known to be pathogenic (PMID: 16714318, 21715711, 26955893). For these reasons, this variant has been classified as Pathogenic. |
Inherited Neuropathy Consortium | RCV000789075 | SCV000928424 | pathogenic | Charcot-Marie-Tooth disease | no assertion criteria provided | literature only |